Faculty of 1000 evaluation for Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial

The Laryngoscope ◽

10.1002/lary.23935 ◽

2013 ◽

Vol 123 (6) ◽

pp. 1334-1340 ◽

Cited By ~ 40

Author(s):

De-Hui Wang ◽

Lei Chen ◽

Lei Cheng ◽

Ke-Nan Li ◽

Hu Yuan ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Clinical and Translational Allergy ◽

10.1186/s13601-017-0180-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 11

Author(s):

Andrzej Bożek ◽

Krzysztof Kołodziejczyk ◽

Renata Kozłowska ◽

Giorgio Walter Canonica

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Subcutaneous Immunotherapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2014.03.019 ◽

2014 ◽

Vol 134 (3) ◽

pp. 568-575.e7 ◽

Cited By ~ 151

Author(s):

Holger Mosbech ◽

Regina Deckelmann ◽

Fréderic de Blay ◽

Elide Anna Pastorello ◽

Ewa Trebas-Pietras ◽

...

Keyword(s):

Asthma Control ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

Clinical & Experimental Allergy ◽

10.1111/cea.12039 ◽

2013 ◽

Vol 43 (2) ◽

pp. 242-248 ◽

Cited By ~ 64

Author(s):

A. Bozek ◽

B. Ignasiak ◽

B. Filipowska ◽

J. Jarzab

Keyword(s):

Allergic Rhinitis ◽

Elderly Patients ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trial

http://isrctn.org/> ◽

10.1186/isrctn91141483 ◽

2012 ◽

Author(s):

H. Moed

Keyword(s):

Allergic Rhinitis ◽

House Dust Mite ◽

Controlled Trial ◽

Mite Allergen ◽

Double Blind ◽

House Dust Mite Allergen ◽

Double Blind Placebo ◽

Dust Mite ◽

Dust Mite Allergen

Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-blind, Placebo-controlled Trial

The Journal of Allergy and Clinical Immunology In Practice ◽

10.1016/j.jaip.2021.10.060 ◽

2021 ◽

Author(s):

Sarah Sella Langer ◽

Renata Nahas Cardili ◽

Janaina Michelle Lima Melo ◽

Mariana Paes Leme Ferriani ◽

Adriana Santos Moreno ◽

...

Keyword(s):

Atopic Dermatitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Cited By ~ 1

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children

Pediatric Allergy and Immunology ◽

10.1111/j.1399-3038.1997.tb00138.x ◽

1997 ◽

Vol 8 (1) ◽

pp. 21-27 ◽

Cited By ~ 127

Author(s):

Th. Hirsch ◽

M. Sähn ◽

W. Leupold

Keyword(s):

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mite Extract ◽

Dust Mite ◽

House Dust Mite Extract

Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study

Journal of Asthma ◽

10.1080/02770903.2018.1541353 ◽

2018 ◽

Vol 56 (12) ◽

pp. 1347-1355 ◽

Cited By ~ 3

Author(s):

Kazuhiro Okamiya ◽

Hisakuni Sekino ◽

Ryuji Azuma ◽

Minoru Kudo ◽

Miyuki Sakaguchi ◽

...

Keyword(s):

Phase I ◽

House Dust ◽

House Dust Mite ◽

Safety Profile ◽

Phase I Study ◽

Japanese Adult ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized, double-blind, placebo-controlled study of Ten-Cha (Rubus suavissimus) on house dust mite allergic rhinitis

Auris Nasus Larynx ◽

10.1016/j.anl.2010.11.017 ◽

2011 ◽

Vol 38 (5) ◽

pp. 600-607 ◽

Cited By ~ 8

Author(s):

Syuji Yonekura ◽

Yoshitaka Okamoto ◽

Kazuki Yamasaki ◽

Shigetoshi Horiguchi ◽

Toyoyuki Hanazawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽